Geron | GERN - Cost Of Sales

Stock Price
1.52
Daily Change
0.06 4.11%
Monthly
10.95%
Yearly
-48.12%
Q1 Forecast
1.33

Geron reported $1.04M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Amgen USD 1.79B 128M Dec/2025
Bio Techne USD 104.6M 6.16M Dec/2025
Cassava Sciences USD 3.96M 1.16M Sep/2025
Cytokinetics USD 112.55M 12.71M Jun/2025
Exelixis USD 18.57M 896K Sep/2025
Genmab DKK 57M 15M Jun/2025
Geron USD 1.04M 147K Sep/2025
Gilead Sciences USD 1.57B 68M Sep/2025
Incyte USD 99M 20.23M Sep/2025
MacroGenics USD 44.3M 5.4M Sep/2025
Novartis USD 3.54B 217M Sep/2025